MKM Partners analyst Eric Handler kept his Buy rating and $28 price target on Imax, saying that while the recent weakness in its stock has been driven by China trade war worries, he believes that the company should not be impacted. The analyst states that he has seen no signs for any tariffs to weigh on the Hollywood film product and also points to IMAX's global box office in China, which is currently "in record territory and outpacing the industry growth rate." Handler adds that the company's Q2 global box office is tracking in line or slightly better than consensus while its back-half film slate also looks "much improved".